Who owns COGENT BIOSCIENCES INC?
- CUSIP Number: 19240qaa0
Tip: Access positions for across all investors
Analyze quarterly positions in Cogent Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Cogent Biosciences stock
Who bought or sold COGENT BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 44M | $52M | 100% | Dec 2025 |
|
| Wolverine Asset Management | 30M | $36M | 64% | Mar 2026 |
|
| Calamos Advisors | 11M | $13M | -17% | Mar 2026 |
|
| Oaktree Capital Management | 10M | $13M | 34% | Mar 2026 |
|
| Lord, Abbett & Co | 8.3M | $10M | 1% | Mar 2026 |
|
| Jump Financial | 8.1M | $9.5M | 100% | Dec 2025 |
|
| Ameriprise Financial | 6.5M | $8.0M | 0% | Mar 2026 |
|
| Polar Capital Holdings | 5.5M | $6.4M | 100% | Dec 2025 |
|
| Wellesley Investment Advisors | 4.6M | $3.3B | 16% | Mar 2026 |
|
| Advent Capital Management | 4.5M | $5.5M | 2% | Mar 2026 |
|
| SSI Investment Management | 4.5M | $5.5M | 0% | Mar 2026 |
|
| Henderson Group | 3.7M | $4.5M | 100% | Mar 2026 |
|
| Leucadia National Corporation | 2.4M | $3.0M | 100% | Mar 2026 |
|
| Millennium Management | 2.0M | $2.4M | 0% | Mar 2026 |
|
| Ares Systematic Credit | 1.8M | $2.1M | 6% | Mar 2026 |
|
| FMR | 1.5M | $1.8M | 100% | Dec 2025 |
|
| Palisade Capital Management | 1.0M | $1.2M | 100% | Dec 2025 |
|
| Agf Management | 1.0M | $1.2M | 100% | Mar 2026 |
|
| Affinity Asset Advisors | 1.0M | $1.2M | 100% | Dec 2025 |
|
| OrbiMed Advisors | 1.0M | $1.2M | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 994k | $1.2M | 100% | Mar 2026 |
|
| Kohlberg Kravis Roberts & Co | 990k | $1.2M | 0% | Mar 2026 |
|
| Gabelli Funds | 950k | $1.1M | 100% | Dec 2025 |
|
| Lazard Asset Management | 506k | $6.2k | 100% | Mar 2026 |
|
| Acasta Partners UK | 500k | $610k | 100% | Mar 2026 |
|
| Central Pacific Bank - Trust Division | 230k | $282k | 100% | Mar 2026 |
|
| Goss Wealth Management | 13k | $13k | 0% | Mar 2026 |
|
Who sold out of Cogent Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ing Investment Management | Dec 2025 | 28M | $33M |
| D. E. Shaw & Co | Dec 2025 | 19M | $22M |
| Sona Asset Management | Dec 2025 | 16M | $19M |
| Polar Securities | Dec 2025 | 7.5M | $8.8M |
| Readystate Asset Management | Dec 2025 | 6.0M | $7.1M |
| Balyasny Asset Management | Dec 2025 | 5.5M | $6.5M |
| Capstone Investment Advisors | Dec 2025 | 3.0M | $3.5M |
| Jane Street | Dec 2025 | 1.0M | $1.2M |